SG48152A1 - Preparation of n-acetyl neuraminic derivatives - Google Patents

Preparation of n-acetyl neuraminic derivatives

Info

Publication number
SG48152A1
SG48152A1 SG1996007395A SG1996007395A SG48152A1 SG 48152 A1 SG48152 A1 SG 48152A1 SG 1996007395 A SG1996007395 A SG 1996007395A SG 1996007395 A SG1996007395 A SG 1996007395A SG 48152 A1 SG48152 A1 SG 48152A1
Authority
SG
Singapore
Prior art keywords
preparation
pct
derivatives
acetyl neuraminic
date jun
Prior art date
Application number
SG1996007395A
Other languages
English (en)
Inventor
Malcolm Chandler
Niall Galbraith Weir
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SG48152A1 publication Critical patent/SG48152A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Glass Compositions (AREA)
SG1996007395A 1991-12-17 1992-12-14 Preparation of n-acetyl neuraminic derivatives SG48152A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919126725A GB9126725D0 (en) 1991-12-17 1991-12-17 Process

Publications (1)

Publication Number Publication Date
SG48152A1 true SG48152A1 (en) 1998-04-17

Family

ID=10706378

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007395A SG48152A1 (en) 1991-12-17 1992-12-14 Preparation of n-acetyl neuraminic derivatives

Country Status (11)

Country Link
US (1) US5495027A (de)
EP (1) EP0623121B1 (de)
JP (1) JP3295082B2 (de)
AT (1) ATE165827T1 (de)
AU (1) AU667860B2 (de)
DE (1) DE69225410T2 (de)
DK (1) DK0623121T3 (de)
ES (1) ES2117976T3 (de)
GB (1) GB9126725D0 (de)
SG (1) SG48152A1 (de)
WO (1) WO1993012105A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
CN103772231B (zh) * 1995-02-27 2016-02-03 吉里德科学公司 新颖化合物，其合成方法及治疗用途
CN100409844C (zh) 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI546306B (zh) 2007-04-11 2016-08-21 第一三共股份有限公司 神經胺酸衍生物之製造方法
JP2012510456A (ja) 2008-11-28 2012-05-10 シプラ・リミテッド ザナミビルの製造方法及び該方法に使用するための中間体
WO2012114350A1 (en) 2011-02-24 2012-08-30 Cadila Healthcare Limited Process for the preparation of zanamivir
US20170100385A1 (en) 2014-05-12 2017-04-13 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions comprising danirixin for treating infectious diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2236717A (en) * 1989-10-11 1991-04-17 David Laurent Giles Monohull fast sealift or semi-planing monohull ship
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.

Also Published As

Publication number Publication date
GB9126725D0 (en) 1992-02-12
DE69225410D1 (de) 1998-06-10
HK1019010A1 (en) 2000-01-14
AU3158893A (en) 1993-07-19
ATE165827T1 (de) 1998-05-15
US5495027A (en) 1996-02-27
EP0623121B1 (de) 1998-05-06
EP0623121A1 (de) 1994-11-09
JPH07502270A (ja) 1995-03-09
AU667860B2 (en) 1996-04-18
JP3295082B2 (ja) 2002-06-24
DE69225410T2 (de) 1998-09-03
WO1993012105A1 (en) 1993-06-24
ES2117976T3 (es) 1998-09-01
DK0623121T3 (da) 1998-10-07

Similar Documents

Publication Publication Date Title
SG48152A1 (en) Preparation of n-acetyl neuraminic derivatives
MX9707431A (es) Inhibidores de la proteina cinasa c.
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
GR3022510T3 (en) Lyospheres comprising gonadotropin
CA2137203A1 (en) Protein kinase c inhibitors
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
PL324490A1 (en) Salts of amidine derivatives with cyclooxygenase inhibitors, method of obtaining them, drugs based on such derivatives and pharmaceutic compositions containing them
ES8702371A1 (es) Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona.
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
WO1992014696A3 (en) SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
TW252971B (de)
IL75357A (en) Primycin components,process for the separation of the antibiotic complex and antibiotic pharmaceutical compositions containing them
IT8820117A0 (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
NZ234451A (en) Benzofuran-substituted 2-imidazoline derivatives and pharmaceutical compositions
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
GR1001203B (el) Μεθοδος παρασκευης της ενωσεως 24r-σκυμνολη.
DE69211161D1 (de) Antibiotische 7-aminonaphthazarinderivate
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
AU4238085A (en) 2,3-diamino-2,3-didesoxyhexose derivatives, processes for their preparation and their use
HU9401458D0 (en) Leukotriene-b4 derivatives, process for preparing the same and medicaments
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
ES8703087A1 (es) Metodo para la estabilizacion de ingredientes efectivos en compuestos de aplicacion oral
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them